CQ’s Carey Discusses Medicare Prescription Drug Price Negotiation Bill; Stem Cell Legislation; FDA Drug Safety, User …
Mary Agnes Carey, associate editor of CQ HealthBeat, examines Senate rejection of legislation that would allow the federal government to negotiate Medicare prescription drug prices, Senate approval of a bill that would expand stem cell research funding and House and Senate discussions on FDA reauth [click link for full article]
Read the rest: Read more here…